Chemical motifs that redox cycle and their associated toxicity
暂无分享,去创建一个
A. Narayanan | R. Naven | Y. Will | L. Jones | Payal Rana
[1] J. Crain,et al. Cyclic denaturation and renaturation of double-stranded DNA by redox-state switching of DNA intercalators. , 2013, Journal of the American Chemical Society.
[2] Kate S. Carroll,et al. Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery , 2013, Chemical reviews.
[3] J. Imlay,et al. Cell Death from Antibiotics Without the Involvement of Reactive Oxygen Species , 2013, Science.
[4] K. Lewis,et al. Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species , 2013, Science.
[5] J. Trojanowski,et al. Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation* , 2013, The Journal of Biological Chemistry.
[6] Nathanael S Gray,et al. Developing irreversible inhibitors of the protein kinase cysteinome. , 2013, Chemistry & biology.
[7] Gregory F Payne,et al. Amplified and in situ detection of redox-active metabolite using a biobased redox capacitor. , 2013, Analytical chemistry.
[8] L. Jones. Chemistry and biology of biomolecule nitration. , 2012, Chemistry & biology.
[9] M. Fraaije,et al. The enigmatic reaction of flavins with oxygen. , 2012, Trends in biochemical sciences.
[10] William Egan,et al. A method for estimating the risk of drug-induced phototoxicity and its application to smoothened inhibitors , 2011 .
[11] W. Chan. Embryonic toxicity of sanguinarine through apoptotic processes in mouse blastocysts. , 2011, Toxicology letters.
[12] A. Stepan,et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.
[13] K. Fritz-Wolf,et al. The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue , 2011, Redox report : communications in free radical research.
[14] J. Taunton,et al. Irreversible Nek2 kinase inhibitors with cellular activity. , 2011, Journal of medicinal chemistry.
[15] Jeffrey D Laskin,et al. Redox cycling and increased oxygen utilization contribute to diquat-induced oxidative stress and cytotoxicity in Chinese hamster ovary cells overexpressing NADPH-cytochrome P450 reductase. , 2011, Free radical biology & medicine.
[16] Paul A Johnston,et al. Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents--real hits or promiscuous artifacts? , 2011, Current opinion in chemical biology.
[17] M. Buděšínský,et al. Flavin-cyclodextrin conjugates as catalysts of enantioselective sulfoxidations with hydrogen peroxide in aqueous media. , 2010, Chemical communications.
[18] P. Workman,et al. Identification by High-Throughput Screening of Viridin Analogs as Biochemical and Cell-Based Inhibitors of the Cell Cycle–Regulated Nek2 Kinase , 2010, Journal of biomolecular screening.
[19] Peter Wipf,et al. Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. , 2010, Assay and drug development technologies.
[20] Nigel Greene,et al. Physicochemical drug properties associated with in vivo toxicological outcomes: a review , 2009, Expert opinion on drug metabolism & toxicology.
[21] W. Pitt,et al. Heteroaromatic rings of the future. , 2009, Journal of medicinal chemistry.
[22] U. Hellmann-Blumberg,et al. Production of hydrogen peroxide and redox cycling can explain how sanguinarine and chelerythrine induce rapid apoptosis. , 2008, Archives of biochemistry and biophysics.
[23] Peter Wipf,et al. Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents. , 2008, Assay and drug development technologies.
[24] S. Thrall,et al. A Simple Assay for Detection of Small-Molecule Redox Activity , 2007, Journal of biomolecular screening.
[25] S. Kitamura,et al. Production of superoxide radical in reductive metabolism of a synthetic food-coloring agent, indigocarmine, and related compounds. , 2005, Life sciences.
[26] D. Hassett,et al. The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.
[27] N. Kitamura,et al. Photoinduced Redox Cycle of Riboflavin at a Water/Oil Interface , 2004, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[28] C. E. Cobb,et al. Reduction and uptake of methylene blue by human erythrocytes. , 2004, American journal of physiology. Cell physiology.
[29] Martin Potthast,et al. Phototoxicity and photogenotoxicity of nine pyridone derivatives. , 2003, Mutation research.
[30] J. Bolton,et al. Role of quinones in toxicology. , 2000, Chemical research in toxicology.
[31] V. Kovtunenko,et al. Condensed isoquinolines. New method of synthesizing derivatives of the 5h-chromeno[2,3-c]isoquinoline system , 1999 .
[32] K. Yoshikawa,et al. The primary cytotoxicity in ultraviolet-a-irradiated riboflavin solution is derived from hydrogen peroxide. , 1995, The Journal of investigative dermatology.
[33] Hirota,et al. Reactivity of 10-Thiaisoalloxazine. : Ring-contraction by Water (Hydroxide Ion) followed by Redox Reaction. , 1991 .
[34] E. Pick,et al. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. , 1980, Journal of immunological methods.
[35] W. Berends,et al. On the origin of the toxicity of toxoflavin. , 1961, Biochimica et biophysica acta.
[36] Siegried Nitzsche. Die Isomeren des N‐Methyl‐acridons und die Oxyacridine , 1943 .
[37] K. Stern,et al. Oxidation-reduction potentials of toxoflavin. , 1935, The Biochemical journal.
[38] Terry L Riss,et al. Cytotoxicity testing: measuring viable cells, dead cells, and detecting mechanism of cell death. , 2011, Methods in molecular biology.
[39] F. Yoneda,et al. Autorecycling in the oxidation of alcohols and amines by 1,6-dimethylpyrimido-[4,5-c]pyridazine-5,7(1H,6H)-diones (4-deazatoxoflavins) , 1980 .
[40] S. Mason. 1002. The tautomerism of N-heteroaromatic hydroxy-compounds. Part II. Ultraviolet spectra , 1957 .